ALLARITY THERAPEUTICS, INC.
Ownership & governance
Executives 5Directors 4Avg age 56Avg tenure 2.8y
TJ
Thomas Jensen
Chief Executive Officer
Age 47Since 2023-12-07Profile →
+8
Executives5
TJ
Thomas Jensen→
Chief Executive Officer
Age 47Since 2023-12-07
SK
Steen Meier Knudsen
Chief Tech/Sci/R&D Officer
Age 65Since 2021-06-30
JE
Jeffrey Ervin
Director of Finance/CFO
Age 48Since 2025-06-30
JG
Jeremy Graff→
President
Age 56Since 2024-10-02
JI
José Iglesias
Chief Tech/Sci/R&D Officer
—Since 2024-10-02
Board of directors4
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Thomas Jensen | 3.751 % | 596,734 |
| Renaissance Technologies LLC | 1.434 % | 228,084 |
| Geode Capital Management LLC | 1.197 % | 190,393 |
| Vanguard Capital Management LLC | 1.08 % | 171,795 |
| Jeffrey Ervin | 0.9428 % | 150,000 |
Catalog · 2026-07-09
SEC officers5
| Name | Role | Since | Shares |
|---|---|---|---|
| Gerald McLaughlin | Chairman | 2023-01-18 | - |
| Jeremy R. Graff | Director or executive officer | — | 24,881 |
| Jesper Høiland | Director/Board Member | 2025-06-29 | - |
| Laura Benjamin | Director/Board Member | 2022-12-31 | - |
| Thomas Jensen | Director/Board Member | 2022-07-06 | - |
SEC · as of 2026-06-26
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 11Range 11–11Analysts 1
- Buy 1
Broker actions6
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Ascendiant Capital | Maintained | Buy | 11 | 2026-09-16 |
| Ascendiant Capital | Maintained | Buy | 10.25 | 2026-06-08 |
| Ascendiant Capital | Maintained | Buy | 9.75 | 2026-04-10 |
| Ascendiant Capital | Maintained | Buy | 9.5 | 2025-12-09 |
| Ascendiant Capital | Maintained | Buy | 9.25 | 2025-09-26 |
| Ascendiant Capital | Initiated | Buy | 9 | 2025-07-28 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.